We Know Exactly Which Viruses Could Spark the Next Pandemic. We're Choosing to Stop Looking.

Four viruses are being monitored right now as potential pandemic threats: mpox, H5N1 bird flu, Oropouche, and rubella. Scientists know their names, track their mutations, and understand which genetic changes would make them dangerous. The surveillance systems designed to catch them early are being dismantled.

The Albis Perception Gap Index scored this story 3.63—coverage exists globally, but the urgency varies sharply depending on whether your country funds pandemic preparedness or slashes it.

The Four Candidates

Mpox has already triggered two global health emergencies. The WHO declared it a crisis in August 2022. Then again in August 2024 when a new clade spread across central Africa. The second emergency ended in September 2025, but the virus didn't disappear—it evolved. More than 100,000 cases were reported globally by early 2026. H5N1 bird flu is what keeps virologists awake at night. It has a 50% fatality rate in humans when it infects. The virus has been spreading through wild birds and poultry since 2020. Then it jumped to US dairy cattle. Scientists describe it as "completely out of control." One mutation could enable human-to-human transmission. That mutation hasn't happened yet. But each new infection gives the virus another chance to roll the dice. Oropouche virus was historically confined to the Amazon rainforest. Not anymore. It's now spreading in Bolivia, Cuba, Panama, and parts of the southeastern United States. The biting midge that carries it is found throughout North and South America. Outbreaks will likely continue affecting travelers in 2026, according to infectious disease specialists. Two confirmed deaths in 2024 marked the first time Oropouche killed humans. Rubella is resurging in countries where MMR vaccination rates dropped during COVID-19. Global MMR coverage fell 3-5% during the pandemic. That might sound small. It's not. Herd immunity requires 95% coverage. The US median is now below that threshold. Stanford researchers warn measles, rubella, and polio could become endemic again if rates keep falling.

The Paradox

We've never been better at spotting threats. The WHO operates a BioHub system. AI-powered epidemic intelligence scans for outbreaks. Genome sequencing can identify mutations within days. Flu surveillance networks span the globe. We know exactly what to watch.

We're also defunding the people doing the watching.

The CDC has lost roughly 3,000 employees since January 2026—about 25% of its workforce. Cuts hit the Global Health Center, the Office of Public Health Data and Surveillance, and the National Center for Chronic Disease Prevention. The FY26 budget eliminates the Prevention and Public Health Fund entirely.

The NIH's Fogarty International Center, which conducts research on global infectious diseases and disease surveillance, faces a proposed $100 million funding cut.

The people tracking H5N1 mutations are losing their jobs in March.

What Surveillance Actually Catches

Disease surveillance isn't just watching case numbers rise. It's genome sequencing to spot mutations. It's coordinating with farms and health departments to test animals and people before outbreaks explode. It's maintaining databases that flag when a virus crosses borders.

When H5N1 spread to US dairy cattle, scientists caught it because surveillance systems were in place. They sequenced the viral genome. They identified which strain it was. They checked whether it had picked up mutations that make human infection easier.

Without that surveillance, the first sign of a pandemic-capable H5N1 variant would be hospitals filling up.

Oropouche's expansion beyond the Amazon was detected through surveillance networks. Mpox's clade shift was spotted because scientists were monitoring for genetic changes. Rubella's resurgence shows up in vaccination databases before outbreaks start.

Strip away the surveillance, and you're flying blind.

The US Response vs Everyone Else's

The US isn't the only country cutting pandemic preparedness. Sharp reductions in aid from high-income countries to lower-income nations in 2025 disrupted vaccination campaigns, disease surveillance, and emergency preparedness across low- and middle-income countries.

But the US cuts hit global systems hardest. The CDC historically funded vaccine-preventable disease surveillance worldwide. US grants supported Tor, VPNs, and circumvention tools that helped dissidents and journalists bypass censorship during outbreaks (those programs were also defunded). The Fogarty Center's research partnerships spanned 100+ countries.

When the US stops funding surveillance, gaps open everywhere.

Some countries are filling them. The WHO Pandemic Fund approved 20 projects in its third funding round, reaching 91 countries. Disease surveillance, laboratory systems, and health workforce training are being strengthened—but on a smaller scale than what's being lost.

What Happens Next

Mpox will keep spreading. H5N1 will keep mutating. Oropouche will keep expanding. Rubella will keep resurging wherever vaccination rates fall.

The question is whether we'll see it coming.

Six years after COVID-19, the world has more tools for pandemic preparedness than ever. We also have less political will to fund them. The infrastructure exists—disease surveillance networks, genome sequencing labs, early warning systems, vaccine manufacturing hubs. It's sitting there. Waiting for money that isn't coming.

Scientists doing the watching are being told to leave. The viruses aren't.

Someone has to pay for pandemic surveillance. For decades, the US did. Now it's not. Other countries are stepping up, but not at the same scale. The Pandemic Fund leverages $1 in grants to mobilize $7 in co-financing—impressive, but it can't replace an entire country walking away.

The detection paradox is simple: we know exactly which viruses could become the next pandemic. We're choosing to stop looking.